These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36173066)

  • 1. Sleep Disturbance, Irritability, and Response to Lurasidone Treatment in Children and Adolescents with Bipolar Depression.
    Singh MK; Siu C; Tocco M; Pikalov A; Loebel A
    Curr Neuropharmacol; 2023; 21(6):1393-1404. PubMed ID: 36173066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lurasidone in Children and Adolescents with Bipolar Depression Presenting with Mixed (Subsyndromal Hypomanic) Features:
    Singh MK; Pikalov A; Siu C; Tocco M; Loebel A
    J Child Adolesc Psychopharmacol; 2020 Dec; 30(10):590-598. PubMed ID: 32392455
    [No Abstract]   [Full Text] [Related]  

  • 3. Major depressive disorder with mixed features and treatment response to lurasidone: A symptom network model.
    Goldberg JF; Siu C; Mao Y; Tsai J; Pikalov A; Calabrese JR; Loebel A
    J Affect Disord; 2020 Dec; 277():1045-1054. PubMed ID: 33065813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. C-reactive protein and response to lurasidone treatment in children and adolescents with bipolar I depression: Results from a placebo-controlled trial.
    Raison CL; Siu C; Pikalov A; Tocco M; Loebel A
    Brain Behav Immun; 2020 Feb; 84():269-274. PubMed ID: 31857217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remission and recovery associated with lurasidone in the treatment of major depressive disorder with subthreshold hypomanic symptoms (mixed features): post-hoc analysis of a randomized, placebo-controlled study with longer-term extension.
    Goldberg JF; Ng-Mak D; Siu C; Chuang CC; Rajagopalan K; Loebel A
    CNS Spectr; 2017 Apr; 22(2):220-227. PubMed ID: 28264739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and Safety of Lurasidone in Children and Adolescents With Bipolar I Depression: A Double-Blind, Placebo-Controlled Study.
    DelBello MP; Goldman R; Phillips D; Deng L; Cucchiaro J; Loebel A
    J Am Acad Child Adolesc Psychiatry; 2017 Dec; 56(12):1015-1025. PubMed ID: 29173735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lurasidone for major depressive disorder with mixed features and irritability: a post-hoc analysis.
    Swann AC; Fava M; Tsai J; Mao Y; Pikalov A; Loebel A
    CNS Spectr; 2017 Apr; 22(2):228-235. PubMed ID: 28300012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerability, Safety, and Effectiveness of Two Years of Treatment with Lurasidone in Children and Adolescents with Bipolar Depression.
    DelBello MP; Tocco M; Pikalov A; Deng L; Goldman R
    J Child Adolesc Psychopharmacol; 2021 Sep; 31(7):494-503. PubMed ID: 34324397
    [No Abstract]   [Full Text] [Related]  

  • 10. Lurasidone in the treatment of bipolar depression with mixed (subsyndromal hypomanic) features: post hoc analysis of a randomized placebo-controlled trial.
    McIntyre RS; Cucchiaro J; Pikalov A; Kroger H; Loebel A
    J Clin Psychiatry; 2015 Apr; 76(4):398-405. PubMed ID: 25844756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features: A Randomized, Double-Blind, Placebo-Controlled Study.
    Suppes T; Silva R; Cucchiaro J; Mao Y; Targum S; Streicher C; Pikalov A; Loebel A
    Am J Psychiatry; 2016 Apr; 173(4):400-7. PubMed ID: 26552942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recovery in bipolar depression: Post-hoc analysis of a placebo-controlled lurasidone trial followed by a long-term continuation study.
    Loebel A; Siu C; Rajagopalan K; Pikalov A; Cucchiaro J; Ketter TA
    J Affect Disord; 2015 Nov; 186():376-82. PubMed ID: 26363720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Lurasidone on Anxiety Symptoms in Patients With Bipolar Depression: A Post Hoc Analysis.
    Goldberg JF; Siu C; Tocco M; Pikalov A; Loebel A
    J Clin Psychiatry; 2023 Jun; 84(4):. PubMed ID: 37339360
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antipsychotics in bipolar disorders].
    Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
    Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjunctive long-acting risperidone in patients with bipolar disorder who relapse frequently and have active mood symptoms.
    Macfadden W; Adler CM; Turkoz I; Haskins JT; Turner N; Alphs L
    BMC Psychiatry; 2011 Oct; 11():171. PubMed ID: 22034906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L; Ketter TA; Cucchiaro J; Loebel A
    J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of cariprazine on reducing symptoms of irritability, hostility, and agitation in patients with manic or mixed episodes of bipolar I disorder.
    Citrome L; Li C; Yu J; Kramer K; Nguyen HB
    J Affect Disord; 2024 Aug; 358():353-360. PubMed ID: 38657773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LURASIDONE IN THE LONG-TERM TREATMENT OF PATIENTS WITH BIPOLAR DISORDER: A 24-WEEK OPEN-LABEL EXTENSION STUDY.
    Ketter TA; Sarma K; Silva R; Kroger H; Cucchiaro J; Loebel A
    Depress Anxiety; 2016 May; 33(5):424-34. PubMed ID: 26918425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term olanzapine therapy in the treatment of bipolar I disorder: an open-label continuation phase study.
    Sanger TM; Grundy SL; Gibson PJ; Namjoshi MA; Greaney MG; Tohen MF
    J Clin Psychiatry; 2001 Apr; 62(4):273-81. PubMed ID: 11379842
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lurasidone in the Long-Term Treatment of Bipolar I Depression: A 28-week Open Label Extension Study.
    Ishigooka J; Kato T; Miyajima M; Watabe K; Masuda T; Hagi K; Higuchi T
    J Affect Disord; 2021 Feb; 281():160-167. PubMed ID: 33321381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.